AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report

Immunotherapy has been an emerging treatment for metastatic melanoma and several other malignancies since 2015. Hematological immune-mediated adverse effects from immunotherapy are rarely reported but they can cause serious harm to patients. Antibodies such as ipilimumab, nivolumab and pembrolizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Dan, AlZahrani, Fatmah, Smylie, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600028/
https://www.ncbi.nlm.nih.gov/pubmed/31275137
http://dx.doi.org/10.1159/000500856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600028/
https://www.ncbi.nlm.nih.gov/pubmed/31275137
http://dx.doi.org/10.1159/000500856

Ejemplares similares